SE0200730L - Kristallin bas av citalopram - Google Patents

Kristallin bas av citalopram

Info

Publication number
SE0200730L
SE0200730L SE0200730A SE0200730A SE0200730L SE 0200730 L SE0200730 L SE 0200730L SE 0200730 A SE0200730 A SE 0200730A SE 0200730 A SE0200730 A SE 0200730A SE 0200730 L SE0200730 L SE 0200730L
Authority
SE
Sweden
Prior art keywords
citalopram
base
salt
crystalline
precipitation
Prior art date
Application number
SE0200730A
Other languages
English (en)
Other versions
SE526022C2 (sv
SE0200730D0 (sv
Inventor
Hans Petersen
Klaus Peter Boegesoe
Per Holm
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8159320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE0200730(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of SE0200730D0 publication Critical patent/SE0200730D0/sv
Publication of SE0200730L publication Critical patent/SE0200730L/sv
Publication of SE526022C2 publication Critical patent/SE526022C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Laminated Bodies (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE0200730A 2000-03-13 2002-03-12 Kristallin bas av citalopram SE526022C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200000402 2000-03-13

Publications (3)

Publication Number Publication Date
SE0200730D0 SE0200730D0 (sv) 2002-03-12
SE0200730L true SE0200730L (sv) 2002-08-29
SE526022C2 SE526022C2 (sv) 2005-06-14

Family

ID=8159320

Family Applications (2)

Application Number Title Priority Date Filing Date
SE0103046A SE517136C2 (sv) 2000-03-13 2001-09-14 Kristallin bas av citalopram
SE0200730A SE526022C2 (sv) 2000-03-13 2002-03-12 Kristallin bas av citalopram

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE0103046A SE517136C2 (sv) 2000-03-13 2001-09-14 Kristallin bas av citalopram

Country Status (42)

Country Link
US (7) US20010031784A1 (sv)
EP (2) EP1169314B2 (sv)
JP (1) JP2003527383A (sv)
KR (1) KR20020080486A (sv)
CN (2) CN1258530C (sv)
AR (1) AR029811A1 (sv)
AT (3) ATE250050T1 (sv)
AU (2) AU746664B2 (sv)
BE (1) BE1013210A3 (sv)
BG (1) BG107065A (sv)
BR (1) BR0109373A (sv)
CA (2) CA2360287C (sv)
CH (2) CH691537A5 (sv)
CZ (1) CZ292077B6 (sv)
DE (7) DE20007303U1 (sv)
DK (3) DK173903B1 (sv)
EA (1) EA200200972A1 (sv)
ES (3) ES2173054T3 (sv)
FI (2) FI20010156A0 (sv)
FR (1) FR2806086B1 (sv)
GB (2) GB2357762B (sv)
GR (1) GR1003796B (sv)
HK (1) HK1054750A1 (sv)
HR (1) HRP20020756A2 (sv)
HU (3) HU0001581D0 (sv)
IE (1) IES20010109A2 (sv)
IL (2) IL147339A (sv)
IS (1) IS5841A (sv)
IT (2) IT1319645B1 (sv)
MX (1) MXPA02008793A (sv)
NL (2) NL1016435C1 (sv)
NO (2) NO312031B1 (sv)
PL (1) PL360158A1 (sv)
PT (2) PT1227088E (sv)
SE (2) SE517136C2 (sv)
SI (2) SI1169314T2 (sv)
SK (1) SK285528B6 (sv)
TR (1) TR200202185T2 (sv)
UA (1) UA74360C2 (sv)
WO (1) WO2001068627A1 (sv)
YU (1) YU68802A (sv)
ZA (1) ZA200207148B (sv)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1173431B2 (en) 1999-04-14 2009-08-26 H. Lundbeck A/S Method for the preparation of citalopram
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
US6299622B1 (en) 1999-08-19 2001-10-09 Fox Hollow Technologies, Inc. Atherectomy catheter with aligned imager
US7708749B2 (en) 2000-12-20 2010-05-04 Fox Hollow Technologies, Inc. Debulking catheters and methods
US7713279B2 (en) 2000-12-20 2010-05-11 Fox Hollow Technologies, Inc. Method and devices for cutting tissue
US7887556B2 (en) 2000-12-20 2011-02-15 Fox Hollow Technologies, Inc. Debulking catheters and methods
US8328829B2 (en) 1999-08-19 2012-12-11 Covidien Lp High capacity debulking catheter with razor edge cutting window
NL1017417C1 (nl) 2000-03-03 2001-03-16 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
IES20010206A2 (en) 2000-03-13 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) * 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
AR032455A1 (es) 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
IS6021A (is) * 2000-08-10 2001-10-20 H. Lundbeck A/S Lyfjasamsetningar sem innihalda sítalópram
GB2376233B (en) * 2000-08-10 2003-09-10 Lundbeck & Co As H Crystals of a pharmaceutically acceptable salt of citalopram wherein the median size of the crystals is at least 40 microns
ATE499054T1 (de) 2000-12-20 2011-03-15 Fox Hollow Technologies Inc Verkleinerungskatheter
EP1462447A3 (en) * 2000-12-22 2004-11-17 H. Lundbeck A/S Method for the preparation of pure citalopram
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.
GB0105627D0 (en) * 2001-03-07 2001-04-25 Cipla Ltd Preparation of phthalanes
MXPA03008777A (es) * 2001-05-01 2004-02-12 Lundbeck & Co As H El uso de escitalopram enantiomericamente puro.
KR20040028947A (ko) 2001-07-31 2004-04-03 하. 룬트벡 아크티에 셀스카브 에시탈로프람 함유 결정 조성물
WO2003057132A2 (en) * 2002-01-07 2003-07-17 Sun Pharmaceutical Industries Limited Process for the preparation of 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile
GB0204607D0 (en) * 2002-02-27 2002-04-10 Matrix Lab Ltd Process
GB2387844B (en) * 2002-02-27 2005-05-11 Matrix Lab Ltd Separation of impurities from a crude mixture of citalopram
GB2385848A (en) * 2002-02-27 2003-09-03 Cipla Ltd Citalopram salts
GB2386119A (en) * 2002-02-27 2003-09-10 Cipla Ltd Purification of citalopram
GB2386118A (en) * 2002-02-27 2003-09-10 Cipla Ltd Citalopram
EP1346989A1 (en) * 2002-03-21 2003-09-24 Jubilant Organosys Limited Improved process for the preparation of citalopram and its hydrobromide
GB0206708D0 (en) * 2002-03-21 2002-05-01 Cipla Ltd Pharmaceutical salts
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
AU2003223105A1 (en) * 2003-03-24 2004-10-18 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
AU2003238676A1 (en) * 2003-04-21 2004-11-19 Podile Khadgapathi An improved process for the preparation of citalopram hydrobromide
US8246640B2 (en) 2003-04-22 2012-08-21 Tyco Healthcare Group Lp Methods and devices for cutting tissue at a vascular location
US7019153B2 (en) 2003-06-10 2006-03-28 Sun Pharmaceutical Industries Limited Process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran acetamido-3-substituted-3-cephem-4-carboxylic acid
GB0317475D0 (en) * 2003-07-25 2003-08-27 Meditab Specialities Pvt Ltd Product
JP4025735B2 (ja) * 2003-08-21 2007-12-26 ローム アンド ハース カンパニー 水性系を処理する方法
GB0320312D0 (en) 2003-08-29 2003-10-01 Novartis Ag Purification process
CN100569765C (zh) 2003-12-19 2009-12-16 杭州民生药业集团有限公司 西酞普兰中间体晶体碱
ITTO20050301A1 (it) * 2005-05-05 2006-11-06 Errekappa Euroterapici Spa Formulazioni liquide orali contenenti citalopram
WO2006123243A2 (en) * 2005-05-20 2006-11-23 Aurobindo Pharma Limited Pharmaceutical dosage forms comprising escitalopram in form of granules
TWI347942B (en) * 2005-06-22 2011-09-01 Lundbeck & Co As H Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
WO2007002597A2 (en) 2005-06-27 2007-01-04 Biovail Laboratories International S.R.L. Modified-release formulations of a bupropion salt
US20070276419A1 (en) 2006-05-26 2007-11-29 Fox Hollow Technologies, Inc. Methods and devices for rotating an active element and an energy emitter on a catheter
US8784440B2 (en) 2008-02-25 2014-07-22 Covidien Lp Methods and devices for cutting tissue
EP2358282B1 (en) 2008-10-13 2017-12-06 Covidien LP Devices for manipulating a catheter shaft
ES2532407T3 (es) 2009-04-29 2015-03-26 Covidien Lp Dispositivos para cortar y raspar tejido
KR101323514B1 (ko) 2009-05-14 2013-10-29 코비디엔 엘피 세척이 용이한 죽상반 절제 카테터 및 사용 방법
CA2781046C (en) 2009-12-02 2014-09-16 Tyco Healthcare Group Lp Methods and devices for cutting tissue
AU2010328078B2 (en) 2009-12-11 2013-07-04 Covidien Lp Material removal device having improved material capture efficiency and methods of use
JP5690928B2 (ja) 2010-06-14 2015-03-25 コヴィディエン リミテッド パートナーシップ 物質除去デバイス
JP5636114B2 (ja) 2010-10-28 2014-12-03 コヴィディエン リミテッド パートナーシップ 物質除去デバイスおよび使用方法
RU2553930C2 (ru) 2010-11-11 2015-06-20 Ковидиен Лп Гибкие фрагментирующие катетеры с визуализацией и способы их использования и изготовления
JP5806407B2 (ja) 2011-09-01 2015-11-10 コヴィディエン リミテッド パートナーシップ 螺旋駆動軸を有するカテーテルおよび製造方法
US9532844B2 (en) 2012-09-13 2017-01-03 Covidien Lp Cleaning device for medical instrument and method of use
US9943329B2 (en) 2012-11-08 2018-04-17 Covidien Lp Tissue-removing catheter with rotatable cutter
WO2015200702A1 (en) 2014-06-27 2015-12-30 Covidien Lp Cleaning device for catheter and catheter including the same
US10314667B2 (en) 2015-03-25 2019-06-11 Covidien Lp Cleaning device for cleaning medical instrument
US10292721B2 (en) 2015-07-20 2019-05-21 Covidien Lp Tissue-removing catheter including movable distal tip
US10314664B2 (en) 2015-10-07 2019-06-11 Covidien Lp Tissue-removing catheter and tissue-removing element with depth stop
US20240024288A1 (en) 2019-07-19 2024-01-25 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2233970A (en) * 1941-03-04 Quinoline compound and process of
US2584429A (en) * 1950-12-29 1952-02-05 Rohm & Haas 1,1-diphenyl-4-tert.-amino-2-butyne-1-ols
GB1143702A (sv) * 1965-03-18
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
DK213290D0 (da) 1990-09-06 1990-09-06 Lundbeck & Co As H Treatment of cerebrovascular disorders
CA2120874E (en) * 1994-04-08 2002-01-08 Keshava Murthy Form of form 1 ranitidine
HU228744B1 (en) * 1997-07-08 2013-05-28 Lundbeck & Co As H Method for preparation of citalopram and intermediates used for them
UA62985C2 (en) * 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
EP1042310B1 (en) * 1997-11-11 2002-07-31 H. Lundbeck A/S Method for the preparation of citalopram
CN1129592C (zh) 1998-10-20 2003-12-03 H·隆德贝克有限公司 制备西酞普兰的方法
EP1173431B2 (en) 1999-04-14 2009-08-26 H. Lundbeck A/S Method for the preparation of citalopram
ITMI991579A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991581A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
US6433196B1 (en) * 2000-02-17 2002-08-13 Sumika Fine Chemicals Co., Ltd. Production method of citalopram, intermediate therefor and production method of the intermediate
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) * 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof

Also Published As

Publication number Publication date
DE1227088T1 (de) 2003-02-06
CA2360287C (en) 2003-09-09
DE20007303U1 (de) 2000-07-27
DE10164687B4 (de) 2006-04-27
HU0100531D0 (en) 2001-03-28
CA2360287A1 (en) 2001-09-20
US20050165244A1 (en) 2005-07-28
NO20010619L (no) 2001-09-14
PT1227088E (pt) 2003-12-31
DK173903B1 (da) 2002-02-11
HUP0100531A3 (en) 2004-04-28
DE20121240U1 (de) 2002-07-04
US20010031784A1 (en) 2001-10-18
SE526022C2 (sv) 2005-06-14
ES2180471T1 (es) 2003-02-16
DE60100786T2 (de) 2004-07-15
GB2357762A (en) 2001-07-04
SE0103046D0 (sv) 2001-09-14
EP1169314A1 (en) 2002-01-09
DE60100786D1 (de) 2003-10-23
SE0103046L (sv) 2001-11-14
CH691537A5 (de) 2001-08-15
SE517136C2 (sv) 2002-04-16
ATE250050T1 (de) 2003-10-15
NL1016435C1 (nl) 2000-11-06
SE0200730D0 (sv) 2002-03-12
PL360158A1 (en) 2004-09-06
HU0001581D0 (en) 2000-06-28
IES20010109A2 (en) 2002-02-20
BE1013210A3 (fr) 2001-10-02
CZ2001808A3 (cs) 2002-01-16
CN1258530C (zh) 2006-06-07
GB0105982D0 (en) 2001-05-02
HK1054750A1 (en) 2003-12-12
CH691477A5 (de) 2001-07-31
US20030078442A1 (en) 2003-04-24
KR20020080486A (ko) 2002-10-23
SK285528B6 (sk) 2007-03-01
FI20010156A0 (sv) 2001-01-25
NO20010619D0 (no) 2001-02-06
ES2180471T3 (es) 2004-05-01
BG107065A (bg) 2003-05-30
ITMI20002425A1 (it) 2002-05-09
PT1169314E (pt) 2002-11-29
DE60100022T3 (de) 2011-11-17
EP1169314B1 (en) 2002-09-04
AU2001100197A4 (en) 2001-09-20
ES2159491A1 (es) 2001-10-01
NL1017413C1 (nl) 2001-09-13
DK1169314T3 (da) 2002-10-14
HU0100450D0 (en) 2001-04-28
SK13132002A3 (sk) 2003-01-09
NO20020356D0 (no) 2002-01-23
AU2001100197B4 (en) 2001-12-06
HRP20020756A2 (en) 2004-12-31
DK1227088T3 (da) 2003-12-22
IL147339A (en) 2004-09-27
ATE223396T1 (de) 2002-09-15
GB2357762B (en) 2002-01-30
IL147339A0 (en) 2002-08-14
SI1169314T2 (sl) 2011-08-31
EP1227088A1 (en) 2002-07-31
NO20020356L (no) 2001-09-14
FR2806086A1 (fr) 2001-09-14
ES2173054T1 (es) 2002-10-16
TR200202185T2 (tr) 2002-12-23
DE10108042A1 (de) 2001-10-18
ZA200207148B (en) 2003-04-23
US20060247451A1 (en) 2006-11-02
CN1680350A (zh) 2005-10-12
IT1319645B1 (it) 2003-10-23
IL158072A0 (en) 2004-03-28
US20040132808A1 (en) 2004-07-08
IS5841A (is) 2001-09-14
EA200200972A1 (ru) 2003-02-27
AR029811A1 (es) 2003-07-16
UA74360C2 (uk) 2005-12-15
US20050165092A1 (en) 2005-07-28
EP1227088B1 (en) 2003-09-17
ES2159491B1 (es) 2002-05-01
CN1429220A (zh) 2003-07-09
CZ292077B6 (cs) 2003-07-16
FR2806086B1 (fr) 2003-05-09
JP2003527383A (ja) 2003-09-16
FI20010225A0 (sv) 2001-02-07
BR0109373A (pt) 2002-12-24
AT4364U1 (de) 2001-06-25
NO315851B1 (no) 2003-11-03
WO2001068627A1 (en) 2001-09-20
SI1169314T1 (en) 2002-12-31
ITMI20010406A1 (it) 2002-08-28
DE60100022T2 (de) 2003-03-06
CA2411732A1 (en) 2001-09-20
AU3725201A (en) 2001-09-13
GR1003796B (el) 2002-02-08
FI109022B (sv) 2002-05-15
EP1169314B2 (en) 2011-06-01
NO312031B1 (no) 2002-03-04
FI20010225A (sv) 2001-09-14
HUP0100531A2 (hu) 2002-01-28
US20040167210A1 (en) 2004-08-26
MXPA02008793A (es) 2003-02-12
YU68802A (sh) 2005-11-28
AU746664B2 (en) 2002-05-02
DE60100022D1 (de) 2002-10-10
SI1227088T1 (en) 2003-12-31
ES2173054T3 (es) 2002-12-16
GB0102797D0 (en) 2001-03-21

Similar Documents

Publication Publication Date Title
SE0200730L (sv) Kristallin bas av citalopram
TW200612195A (en) Oxime derivatives and the use therof as latent acids
HK1167658A1 (en) Composition for the preparation of 17-vinyl- triflates as intermediates 17--
CO5601030A2 (es) Derivados de quinolinona/benzoxazinona y usos de los mismos
NO20050612L (no) Pyrrolidinderivater som oksytocinantagonister
HRP20050424A2 (en) Process for making risperidone and intermediates thereof
DE60306667D1 (de) Cefdinir salze als zwischenprodukte
UY27842A1 (es) Fluorobenzamidas
NO20002589D0 (no) Bifenylamidinderivater
AR038624A1 (es) Un procedimiento para preparar un derivado de fenilalanina e intermediarios del mismo
AR027559A1 (es) Metodo para la preparacion de citalopram
AR037005A1 (es) Derivados de acidos dimetilfenilaceticos, derivados de piperidina, y proceso para la produccion de derivados de piperidina.
ATE257832T1 (de) Verfahren zur herstellung von citalopram
AR029893A1 (es) Metodo para la preparacion de citalopram, intermediarios y composicion farmaceutica
NO330965B1 (no) Fremgangsmate for fremstilling av substituerte imidazolderivater, mellomprodukter anvendt i fremgangsmaten samt fremgangsmate for fremstilling av mellomprodukt
NO20032314D0 (no) Nye desloratadinsalter, fremgangsmåte for deres syntese og farmasöytiske preparater derav
AR019197A1 (es) COMPUESTOS DERIVADOS DE PIPERIDINA ANTIHISTAMINICOS, COMPUESTOS INTERMEDIOS, PROCEDIMIENTO DE PREPARACIoN DE DERIVADOS DE PIPERIDINA Y PROCEDIMIENTOS DE PREPARACIoN DE INTERMEDIARIOS.
DE602004015310D1 (de) Verfahren zur herstellung von mycophenolatmofetil
ATE420067T1 (de) Peptid-derivate und ihre pharmazeutisch akzeptablensalze, verfahren zur herstellung von beiden und ihre verwendung
PE20030758A1 (es) 1,3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion
YU34303A (sh) Postupak za proizvodnju 4-(17alfa-supstituisani-3-oksoestra -4,9-dien-11beta-il)benzaldehid-(1e ili 1z)-oksima
FR2835834B1 (fr) Nouveaux derives de tricyclo-imidazolines, leur procede de preparation et leur utilisation a titre de medicaments
DK1423385T3 (da) Mellemprodukter til fremstilling af neuraminidaseinhibitorkonjugater
AR036680A1 (es) Procedimiento para preparar derivados de heterocicloalquilsulfonilpirazol y compuestos utiles en su preparacion
MY142362A (en) Pharmaceutical composition for promoting angiogenesis

Legal Events

Date Code Title Description
NUG Patent has lapsed